Parabilis Medicines, Inc. (PBLS)
38.43
-0.93
(-2.36%)
USD |
NASDAQ |
Aug 24, 16:00
38.53
+0.10
(+0.26%)
After-Hours: 20:00
Parabilis Medicines Shareholders Equity (Quarterly) : 1.048B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.048B |
| Date | Value |
|---|---|
| March 31, 2026 | 244.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna, Inc. | 6.761B |
| Kailera Therapeutics, Inc. | 1.118B |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.175B |
| Total Liabilities (Quarterly) | 127.53M |
| Debt to Equity Ratio | 0.0453 |
| Current Ratio | 17.91 |
| Net Debt Paydown Yield | -0.22% |